Suchergebnisse
ANIP Stock Outlook: Cortrophin Growth vs. Retina Reset
ANI Pharmaceuticals ANIP is reshaping its growth profile as specialty therapies take a larger share of the mix. Fiscal 2025 results show accelerating momentum in Rare Disease and Brands, led by
Is IonQ (IONQ) a Buy as Wall Street Analysts Look Optimistic?
Investors often turn to recommendations made by Wall Street analysts before making a Buy, Sell, or Hold decision about a stock. While media reports about rating changes by these brokerage-firm
Wall Street Bulls Look Optimistic About Micron (MU): Should You Buy?
Investors often turn to recommendations made by Wall Street analysts before making a Buy, Sell, or Hold decision about a stock. While media reports about rating changes by these brokerage-firm
Is It Worth Investing in QuickLogic (QUIK) Based on Wall Street's Bullish Views?
Investors often turn to recommendations made by Wall Street analysts before making a Buy, Sell, or Hold decision about a stock. While media reports about rating changes by these brokerage-firm
Is Broadcom Inc. (AVGO) a Buy as Wall Street Analysts Look Optimistic?
Investors often turn to recommendations made by Wall Street analysts before making a Buy, Sell, or Hold decision about a stock. While media reports about rating changes by these brokerage-firm
Is Commvault (CVLT) a Buy as Wall Street Analysts Look Optimistic?
Investors often turn to recommendations made by Wall Street analysts before making a Buy, Sell, or Hold decision about a stock. While media reports about rating changes by these brokerage-firm
Wall Street Bulls Look Optimistic About Advanced Micro (AMD): Should You Buy?
Investors often turn to recommendations made by Wall Street analysts before making a Buy, Sell, or Hold decision about a stock. While media reports about rating changes by these brokerage-firm
EQS-News: The TRATON GROUP and Applied Intuition announce TRATON ONE OS, a Unified Software Platform for improved fleet uptime across TRATON’s four global brands
EQS-News: tick Trading Software AG veröffentlicht Geschäftsbericht 2024/2025 und lädt zur ordentlichen Hauptversammlung 2026 ein
Tenax Therapeutics Aktie: Meilenstein erreicht
Tenax Therapeutics nähert sich einem entscheidenden Wendepunkt in seinem klinischen Programm. Nachdem das Unternehmen…
Der Beitrag Tenax Therapeutics Aktie: Meilenstein erreicht erschien zuerst auf
SSRM's $1.5B Copler Sale Signals a Shift to the Americas
SSR Mining SSRM is moving to simplify its story. A definitive agreement to monetize its majority interest in the suspended Çöpler mine would remove a persistent cost overhang and sharpen the
Should You Invest in the Invesco Building & Construction ETF (PKB)?
Designed to provide broad exposure to the Industrials - Engineering and Construction segment of the equity market, the Invesco Building & Construction ETF (PKB) is a passively managed exchange
Expanding Wafer Fab Equipment Spending Aids KLAC: What's Ahead?
KLA KLAC is benefiting from strong spending in the Wafer Fabrication Equipment (“WFE”) market. The company expects the WFE market to grow from about $110 billion in 2025 to the mid-$130 billion
Should You Invest in the Invesco S&P 500 Equal Weight Consumer Discretionary ETF (RSPD)?
Designed to provide broad exposure to the Consumer Discretionary - Broad segment of the equity market, the Invesco S&P 500 Equal Weight Consumer Discretionary ETF (RSPD) is a passively managed
Sartorius Stedim Biotech SA: DECLARATION RELATIVE TO THE NUMBER OF SHARES AND VOTING RIGHTS MAKING UP THE ISSUED CAPITAL
Accelerant Holdings (ARX) Reports Q4 Earnings: What Key Metrics Have to Say
For the quarter ended December 2025, Accelerant Holdings (ARX) reported revenue of $248.4 million, representing no change compared to the same period last year. EPS came in at $0.23, compared to $0
Canadian Solar Q4 Loss Wider Than Estimates, Revenues Fall Y/Y
Canadian Solar, Inc. CSIQ reported fourth-quarter 2025 adjusted loss of $1.66 per share, wider than the Zacks Consensus Estimate of a loss of $1.10. The loss widened compared with the year-ago
Forget Iran War: Bet Big on Tech ETFs on Earnings Strength
As the 2025 fourth-quarter earnings season nears its end, corporate profitability remains robust and is showing clear signs of improvement. The Tech sector remains a bright spot in the earnings
FactSet (FDS) Q2 Earnings Preview: What You Should Know Beyond the Headline Estimates
The upcoming report from FactSet Research (FDS) is expected to reveal quarterly earnings of $4.37 per share, indicating an increase of 2.1% compared to the year-ago period. Analysts forecast





